adpribosyl
ubiquit
posttransl
addit
either
monom
polym
adpribos
target
protein
adpribosyltransferas
usual
interferoninduc
diphtheria
toxinlik
enzym
known
parp
sever
parp
known
antivir
activ
activ
mostli
independ
adpribosyl
consequ
less
known
antivir
effect
adpribosyl
sever
viral
famili
includ
coronavirida
togavirida
hepevirida
encod
macrodomain
protein
bind
hydrolyz
adpribos
protein
critic
optim
replic
virul
result
suggest
macrodomain
counter
cellular
adpribosyl
whether
parp
altern
adpribosyltransferas
caus
modif
clear
show
panparp
inhibit
enhanc
replic
inhibit
interferon
product
primari
macrophag
infect
macrodomainmut
wildtyp
coronaviru
specif
knockdown
two
abundantli
express
parp
led
increas
replic
mutant
significantli
affect
wildtyp
viru
also
import
induct
interferon
mous
human
cell
indic
critic
role
parp
regul
innat
immun
summari
data
demonstr
macrodomain
requir
prevent
parpmedi
inhibit
coronaviru
replic
enhanc
interferon
product
author
summari
adpribosyl
understudi
posttransl
modif
facilit
host
respons
viru
infect
sever
virus
includ
member
coronaviru
plo
pathogen
http
doi
introduct
adpribosyl
posttransl
coval
addit
singl
monoadpribosyl
maryl
multipl
polyadpribosyl
paryl
subunit
adpribos
nad
protein
process
catalyz
intracellular
poli
adpribos
polymeras
parp
also
known
diphtheria
toxinlik
adpribosyltransferas
artd
although
extracellular
cholera
toxinlik
adpribosyltransferas
artc
sirtuin
also
catalyz
adpribosyl
human
encod
parp
mice
encod
four
paryl
rest
maryl
nonenzymat
like
mani
posttransl
modif
adpribosyl
revers
enzym
poli
adpribos
glycohydrolas
parg
adpribosylhydrolas
arh
macrodomain
adpribosyl
alter
structur
function
substrat
protein
implic
sever
process
includ
dna
damag
repair
cellular
stress
respons
viru
infect
instanc
paryl
parp
regul
sever
nuclear
process
dna
repair
transcript
wnt
pathway
activ
monoadpribosyl
parp
also
play
varieti
role
cell
biolog
exampl
requir
activ
erstress
pathway
bind
enhanc
gene
express
augment
gene
express
macrophag
unknown
adpribosyl
enzym
inhibit
rnai
follow
stress
respons
poli
c
treatment
addit
two
sirtuin
use
adpribosyl
inhibit
glutam
dehydrogenas
promot
dna
repair
respect
parp
evolv
rapidli
may
reflect
involv
viru
infect
consist
sever
parp
known
isg
interferon
stimul
gene
mani
parp
shown
antivir
also
call
zinc
antivir
protein
zap
inhibit
replic
multipl
class
virus
includ
retrovirus
alphavirus
filovirus
bind
viral
rna
recruit
rnadegrad
exosom
complex
zap
also
found
requir
adpribosyl
subsequ
degrad
influenza
viru
protein
pa
despit
catalyt
inact
atasheva
et
al
demonstr
exogen
express
parp
inhibitori
effect
protein
translat
venezuelan
equin
enceph
viru
veev
viru
replic
use
adpribosylationdepend
independ
mechan
group
other
demonstr
could
also
inhibit
vesicular
stomat
viru
vsv
rift
valley
fever
viru
rvfv
encephalomyocard
viru
emcv
shown
restrict
zika
viru
replic
promot
degrad
viral
protein
adpribosylationdepend
manner
shown
complex
ubiquitin
ligas
ubiquitin
host
histon
enhanc
ifn
signal
result
inhibit
rna
viru
replic
complex
also
target
emcv
proteas
ubiquitin
degrad
import
activ
whether
adpribosyl
activ
requir
unclear
case
adpribosyl
import
effici
viru
replic
inhibitor
restrict
replic
sever
virus
herpesvirus
adenovirus
hiv
antiand
provir
activ
bind
induc
degrad
sindbi
viru
rna
also
promot
influenza
viru
infect
adpribosyl
inhibit
type
ifn
ifni
product
final
sirtuin
includ
adpribosyl
sirtuin
shown
inhibit
replic
wide
varieti
dna
rna
virus
cell
howev
mechan
viral
inhibit
sirtuin
whether
adpribosyl
involv
remain
unknown
togavirida
coronavirida
hepevirida
encod
macrodomain
protein
remov
adpribos
protein
vitro
sever
residu
identifi
import
macrodomain
activ
fall
adpribos
bind
pocket
recombin
alphavirus
hepat
e
viru
hev
mutat
residu
gener
replic
well
macrodomainmut
coronavirus
gener
replic
normal
tissu
cultur
cell
highli
attenu
vivo
collect
result
suggest
viral
macrodomain
counter
cellular
adpribosyl
whether
parp
artc
sirtuin
unknown
adpribosyltransferas
mediat
adpribosyl
lead
attenu
macrodomainmut
virus
still
unknown
coronavirus
cov
envelop
positivesens
rna
virus
caus
sever
diseas
sever
mammalian
speci
porcin
epidem
diarrhea
viru
porcin
delta
coronaviru
caus
sever
diseas
agricultur
import
anim
other
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
caus
lethal
human
diseas
mous
hepat
viru
strain
jhmv
term
mhv
herein
caus
acut
chronic
demyelin
encephalomyel
prototyp
cov
use
mani
studi
cov
maintain
sever
protein
import
block
innat
immun
respons
includ
enzym
omethyltransferas
nsp
nonstructur
protein
deubiquitinas
dub
endoribonucleas
adpribosylhydrolas
aforement
macrodomain
accordingli
sarscov
macrodomainmut
viru
shown
induc
robust
proinflammatori
cytokin
respons
follow
infect
vitro
vivo
addit
sarscov
human
cov
macrodomainmut
virus
increas
sensit
ifni
treatment
cell
cultur
demonstr
cov
macrodomain
counter
antivir
activ
isg
togeth
studi
suggest
ifnstimul
adpribosyl
counter
conserv
cov
macrodomain
show
parp
inhibitor
specif
enhanc
replic
mhv
decreas
ifn
product
macrodomainmut
viru
infect
implic
macrodomain
counter
ifninduc
parpmedi
antivir
adpribosyl
mice
infect
neurovirul
mhv
develop
lethal
enceph
studi
role
viral
macrodomain
mhvinduc
neurolog
diseas
previous
creat
recombin
viru
contain
alanin
mutat
highli
conserv
asparagin
residu
herein
denot
mhv
viru
locat
macrodomain
within
mhv
specif
locat
mutat
previous
report
asparagin
residu
present
enzymat
activ
macrodomain
asparaginetoalanin
mutat
either
reduc
chikv
hev
abolish
sarscov
adpribosyl
hydrolas
activ
viral
macrodomain
structur
locat
residu
within
protein
highli
conserv
among
cov
macrodomain
appear
coordin
oh
distal
ribos
influenc
adpribos
bind
catalysi
mhv
replic
poorli
caus
diseas
mice
indic
import
residu
macrodomain
function
macrophag
play
central
role
protect
infect
viru
caus
sever
diseas
microglia
deplet
brain
directli
assess
replic
mutant
viru
macrophag
vivo
purifi
cell
puriti
fig
brain
mice
infect
wildtyp
wt
mhv
contain
egfp
place
note
requir
optim
viru
replic
vitro
vivo
herein
wt
viru
refer
previous
describ
viru
wt
macrodomain
sequenc
reinsert
mhv
bac
clone
similar
result
found
whole
brain
viru
replic
measur
viral
genom
rna
grna
content
reduc
compar
wt
viru
isol
brain
cell
fig
macrodomain
predict
counter
parpmedi
adpribosyl
also
analyz
whether
parp
express
chang
infect
consist
role
adpribosyl
sever
parp
highli
upregul
cell
follow
infect
either
wt
viru
fig
date
cell
cultur
system
exist
cov
macrodomainmut
viru
robust
growth
defect
sinc
brainderiv
cell
practic
molecular
studi
next
examin
whether
bone
marrowderiv
macrophag
bmdm
could
recapitul
replic
defici
mhv
seen
vivo
end
harvest
murin
bone
marrow
cell
differenti
macrophag
infect
bmdm
wt
viru
low
multipl
infect
moi
fig
hour
post
infect
hpi
bmdm
infect
viru
lower
titer
grna
level
infect
wt
viru
fig
furthermor
total
viral
protein
level
notic
decreas
virusinfect
cell
measur
immunoblot
nucleocapsid
n
protein
fig
visual
analyz
virusencod
gfp
express
syncytia
format
fluoresc
microscopi
fig
unfortun
larg
syncytia
form
infect
cell
made
quantit
flow
cytometr
analysi
gfpexpress
cell
unfeas
previous
observ
diminish
innat
immun
respons
brain
mice
infect
viru
like
reflect
diminish
viru
replic
determin
inactiv
macrodomain
mhv
also
inhibit
innat
immun
respons
infect
bmdm
quantifi
ifni
cytokin
product
infect
either
wt
viru
howev
contrast
result
seen
infect
mice
transcript
level
secret
level
protein
significantli
increas
hpi
bmdm
infect
viru
compar
level
wt
virusinfect
sampl
fig
suggest
cov
macrodomain
inhibit
innat
immun
respons
infect
bmdm
determin
restrict
mhv
replic
due
mechan
upstream
downstream
ifni
signal
infect
bmdm
isol
wt
mav
mitochondri
antivir
signal
protein
ifnar
interferon
receptor
mice
wt
mhv
loss
mav
ifnar
greatli
reduc
mrna
level
compar
wt
cell
fig
furthermor
mhvmediat
increas
mrna
seen
wt
cell
ablat
mav
cell
fig
howev
replic
defici
viru
wt
bmdm
retain
mav
cell
larg
rescu
ifnar
cell
measur
genom
rna
level
viral
titer
visual
gfp
express
fig
determin
vitro
find
correl
virul
infect
wt
mav
ifnar
mice
intranas
wt
viru
fig
virusinfect
wt
mav
mice
exhibit
surviv
minim
differ
weight
loss
contrast
ifnar
mice
infect
viru
succumb
infect
exhibit
weight
loss
similar
induc
wt
viru
confirm
factor
limit
mhv
replic
downstream
ifni
genom
rna
grna
level
b
determin
plaqu
assay
rtqpcr
primer
specif
normal
hprt
respect
c
bmdm
infect
describ
hpi
viral
protein
level
determin
immunoblot
infect
cell
lysat
antinucleocapsid
protein
n
antibodi
c
visual
fluoresc
microscopi
e
infect
bmdm
collect
indic
time
point
rna
level
determin
rtqpcr
primer
specif
transcript
normal
hprt
f
bmdm
infect
describ
hpi
supernat
collect
analyz
protein
level
elisa
data
ae
obtain
one
experi
repres
two
independ
experi
n
biolog
replic
data
f
combin
two
independ
experi
wt
n
n
number
bar
repres
fold
differ
wt
macrodomain
adpribosylhydrolas
rais
possibl
parp
enzym
respons
attenu
viru
parp
known
isg
lack
upregul
protein
ifnar
cell
mice
could
explain
restor
mhvspecif
phenotyp
first
determin
whether
parp
upregul
infect
measur
parp
mrna
level
bmdm
infect
wt
viru
fig
sever
parp
famili
member
includ
parp
upregul
wt
virusinfect
bmdm
compar
mockinfect
cell
note
primer
design
detect
isoform
unabl
detect
furthermor
express
upregul
parp
also
increas
infect
mav
cell
express
parp
increas
infect
ifnar
cell
fig
suggest
parp
isg
consist
previou
report
confirm
treat
wt
ifnar
bmdm
measur
parp
mrna
level
fig
expect
parp
addit
parp
upregul
follow
stimul
wt
ifnar
bmdm
consist
previou
studi
interestingli
induc
also
induc
infect
ifnar
cell
demonstr
parp
isg
also
regul
addit
mechan
infect
fig
conclud
parp
isg
primari
murin
macrophag
parp
highli
express
follow
cov
infect
directli
test
whether
parp
inhibit
cov
replic
facilit
ifni
product
absenc
macrodomain
adpribosylhydrolas
activ
infect
cell
wt
mhv
prior
treatment
parp
inhibitor
fig
gener
parp
inhibitor
develop
inhibitor
higher
concentr
inhibit
parp
inhibitor
affect
cell
growth
metabol
concentr
use
studi
diminish
cellular
paryl
demonstr
efficaci
fig
importantli
inhibitor
significantli
increas
viru
replic
compar
vehicl
treatment
visual
gfp
express
measur
viral
titer
genom
rna
level
fig
level
transcript
produc
virusinfect
cell
treat
inhibitor
reduc
level
seen
wt
virusinfect
cell
fig
importantli
neither
inhibitor
signific
effect
replic
ifn
product
wt
virusinfect
cell
suggest
parp
potenti
counteract
macrodomain
activ
wt
infect
inhibitor
known
target
parp
catalyt
site
data
indic
parpcatalyz
adpribosyl
respons
decreas
replic
increas
product
mhv
infect
determin
individu
parp
restrict
replic
mhv
transfect
bmdm
sirna
highli
express
parp
examin
effect
wt
viru
replic
unabl
reliabl
knockdown
express
parp
exclud
analysi
knockdown
test
parp
mrna
wt
mhvinfect
bmdm
observ
fig
knockdown
parp
significantli
increas
wt
viru
grna
level
control
sirnatransfect
virusinfect
cell
fig
top
row
contrast
two
independ
sirna
direct
toward
significantli
rescu
viru
grna
level
without
signific
effect
wt
viru
fig
bottom
row
viral
titer
also
increas
cell
transfect
although
increas
replic
viru
knockdown
cell
reach
statist
signific
fig
examin
role
mhv
infect
infect
bmdm
harvest
mice
fig
viru
replic
significantli
differ
cell
fig
suggest
parp
factor
import
restrict
replic
may
compens
lack
congenit
absenc
effort
resolv
differ
util
recent
develop
inhibitor
compound
target
maryl
catalyt
site
fig
compound
affect
cell
viabil
metabol
inhibit
global
cellular
paryl
fig
significantli
restor
replic
viru
bmdm
fig
gener
result
support
role
block
mhv
replic
howev
whether
catalyt
domain
requir
role
requir
valid
impact
innat
immun
signal
pathway
also
test
whether
inhibitor
affect
ifn
product
found
addit
partial
rescu
mhv
replic
fig
inhibitor
caus
reduct
mrna
level
wt
virusinfect
bmdm
fig
consist
result
contrast
cell
show
increas
ifn
express
follow
infect
viru
fig
notabl
overexpress
gfp
fig
overexpress
mutant
inactiv
mutat
catalyt
triad
parp
domain
cm
describ
also
induc
ifn
express
dbt
cell
follow
transfect
fig
result
suggest
adpribosylationdepend
independ
mechan
regul
ifn
respons
determin
whether
also
import
ifn
induct
human
cell
use
assay
base
ifnmedi
inhibit
vsv
vesicular
stomat
viru
replic
engin
six
knockout
ko
clone
cell
pool
ko
cell
normal
human
dermal
fibroblast
nhdf
use
fig
cell
transfect
poli
c
hour
point
supernat
condit
media
collect
transfer
cell
incub
infect
cell
egfpexpress
mutant
recombin
vsv
vsv
unabl
suppress
innat
immun
respons
measur
viru
replic
plaqu
assay
vero
cell
quantifi
amount
antivir
cytokin
condit
media
fig
expect
treatment
condit
media
poli
c
transfect
wt
fig
wt
nhdf
cell
fig
induc
substanti
decreas
vsv
replic
compar
media
mocktransfect
cell
contrast
condit
media
harvest
stimul
ko
fig
ko
nhdf
fig
cell
show
partial
antivir
activ
result
enhanc
replic
vsv
compar
cell
receiv
condit
media
stimul
wt
cell
confirm
antivir
activ
condit
media
due
ifni
engin
cell
function
knock
test
whether
condit
media
effect
vsv
replic
cell
addit
exogen
ifnar
ko
cell
effect
vsv
replic
wherea
unit
restrict
vsv
replic
wt
cell
confirm
ifnar
ko
cell
defect
ifni
signal
fig
condit
media
wt
ko
cell
treat
poli
c
still
mild
inhibitori
effect
vsv
replic
ifnar
ko
cell
suggest
antivir
cytokin
addit
ifni
present
media
howev
smaller
differ
vsv
replic
wt
ko
condit
mediatr
cell
observ
ifnar
ko
recipi
cell
compar
wt
recipi
cell
fig
indic
primari
antivir
factor
produc
stimul
cell
ifni
taken
togeth
data
indic
necessari
effici
ifni
product
cov
infect
poli
c
stimul
mous
human
cell
respect
show
parp
specif
requir
inhibit
replic
macrodomainmut
cov
also
requir
optim
ifn
hpi
rna
level
determin
rtqpcr
viral
titer
determin
plaqu
assay
b
data
repres
combin
result
two
five
experi
n
n
n
n
n
n
n
n
result
b
show
one
experi
repres
two
independ
experi
c
litterm
control
bmdm
infect
wt
viru
cell
collect
hpi
grna
level
determin
rtqpcr
data
c
show
one
experi
repres
four
independ
experi
structur
inhibitor
compound
e
bmdm
infect
wt
viru
treat
compound
vehicl
dmso
follow
adsorpt
phase
cell
collect
hpi
grna
level
determin
rtqpcr
data
e
repres
combin
result
four
experi
n
number
bar
repres
fold
differ
wt
siparpsictl
inhibitordmsotr
cell
infect
viru
http
express
previou
report
shown
cov
unabl
caus
diseas
absenc
viral
macrodomain
adpribosylhydrolas
activ
attenu
associ
reduc
viral
load
chang
proinflammatori
cytokin
express
vivo
howev
difficult
elucid
detail
cov
macrodomain
function
due
lack
cell
cultur
system
recapitul
phenotyp
result
show
bmdm
use
purpos
sinc
mhv
replic
poorli
induc
robust
ifn
respons
cell
fig
bmdm
provid
sever
advantag
primari
cell
easili
cultur
obtain
larg
number
fulli
function
innat
immun
respons
product
infect
mhv
parp
antivir
immunomodulatori
role
found
panparp
inhibitor
decreas
ifn
product
enhanc
replic
mhv
lack
adpribosylhydrolas
activ
signific
effect
wt
viru
fig
antivir
properti
parp
depend
upon
adpribosyltransferas
activ
sinc
inhibitor
target
catalyt
site
parp
result
suggest
conserv
cov
macrodomain
function
directli
counter
activ
cellular
parp
enzym
howev
conclus
requir
valid
addit
util
sirna
knockdown
specif
inhibitor
provid
evid
necessari
restrict
viru
replic
fig
high
sequenc
similar
zap
previous
shown
block
cellular
viral
protein
translat
inhibit
viru
replic
adpribosyl
depend
independ
mechan
hand
previous
shown
inhibit
viru
replic
rather
shown
modul
innat
adapt
immun
respons
protein
known
compon
stress
granul
interact
varieti
protein
includ
argonaut
zap
interestingli
recent
shown
adpribosyl
human
cell
intrigu
determin
local
stress
granul
cov
infect
ii
whether
involv
restrict
mhv
replic
iii
parp
specif
impact
cov
lifecycl
import
identifi
protein
adpribosyl
parp
target
macrodomain
infect
fulli
understand
import
hostviru
interact
sinc
macrodomain
subunit
within
larg
transmembran
viral
protein
like
target
deadpribosyl
cellular
protein
close
vicin
includ
protein
locat
replicationtranscript
complex
rtc
subcellular
structur
pbodi
stress
granul
studi
chikungunya
viru
sindbi
viru
demonstr
alphaviru
macrodomain
also
counter
cellular
adpribosyl
mutant
decreas
adpribos
bind
enzymat
activ
mild
sever
replic
defect
howev
follow
infect
chikungunya
viru
littl
parp
induct
observ
infect
cell
maryl
inhibitor
decreas
wt
viru
replic
thu
parp
play
antivir
role
cov
infect
role
alphaviru
infect
may
nuanc
half
parp
famili
member
induc
mhv
infect
bmdm
fig
rais
possibl
parp
addit
contribut
antivir
respons
consist
panparp
inhibitor
reduc
mhvinduc
ifni
level
fig
much
effect
inhibitor
fig
notabl
express
follow
infect
upregul
infect
ifnar
bmdm
fig
suggest
part
ifnindepend
cellular
respons
infect
addit
knockdown
either
mrna
mildli
reduc
grna
product
cell
infect
either
wt
viru
fig
suggest
provir
function
mhvinfect
bmdm
perhap
analog
alphavirusinfect
cell
contrast
viru
infect
model
known
antivir
final
use
recent
develop
inhibitor
bmdm
fig
well
human
ko
nhdf
cell
fig
fig
found
requir
robust
ifni
product
cov
infect
poli
c
stimul
data
consist
recent
report
detail
role
ifni
induct
follow
lp
stimul
raw
cell
bmdm
studi
absenc
affect
transloc
nucleu
rather
alter
histon
modif
reduc
pol
ii
recruit
specif
isg
promot
nucleu
consist
data
also
show
overexpress
induc
ifni
transcript
dbt
cell
fig
three
inactiv
mutat
catalyt
triad
also
induc
ifn
express
fig
suggest
use
adpribosedepend
independ
mechan
regul
ifn
respons
cov
infect
result
may
surpris
sinc
fragment
without
catalyt
domain
shown
activ
depend
transcript
catalyt
domain
requir
maxim
activ
mani
signal
protein
involv
product
ifni
isg
known
regul
posttransl
modif
phosphoryl
ubiquitin
recent
sever
protein
demonstr
regul
parp
well
find
along
data
unveil
previous
unknown
mechan
innat
immun
regul
suggest
parpdepend
adpribosyl
impact
sever
protein
pathway
clearli
next
step
identifi
target
individu
parp
determin
precis
adpribosyl
regul
innat
immun
respons
anim
studi
approv
univers
iowa
institut
anim
care
use
committe
iacuc
direct
guid
care
use
laboratori
anim
protocol
anesthesia
euthanasia
accomplish
use
isofluran
ketaminexylazin
ketaminexylazin
respect
previous
describ
obtain
gener
gift
dr
mark
boothbi
vanderbilt
univers
nashvil
tn
obtain
gener
gift
dr
oberdan
leo
universit
libr
de
bruxel
goss
belgium
mous
human
purchas
pbl
assay
scienc
purchas
apexbio
compound
previous
describ
follow
differenti
bmdm
treat
indic
compound
hour
cell
viabil
assess
use
vybrant
mtt
cell
prolifer
assay
thermo
fisher
scientif
follow
manufactur
instruct
pathogenfre
wt
ifnar
mice
purchas
jackson
laboratori
mav
mice
obtain
gener
gift
dr
michael
gale
univers
washington
seattl
washington
mice
bred
maintain
anim
care
facil
univers
iowa
mice
gener
gift
dr
mark
boothbi
vanderbilt
univers
nashvil
tennesse
bred
maintain
anim
care
facil
harvard
medic
school
recombin
wt
rj
ia
rj
ia
mhv
previous
describ
virus
express
egfp
viru
stock
creat
infect
cell
moi
plaqueform
unit
pfu
cell
collect
cell
supernat
hpi
cell
freezethaw
debri
remov
prior
collect
viru
stock
viru
stock
quantifi
plaqu
assay
helamhvr
cell
bmdm
cell
infect
mhv
moi
pfucel
min
adsorpt
phase
infect
cell
incub
collect
indic
timepoint
recombin
egfpexpress
mutant
vsv
obtain
dr
dougla
lyle
wake
forest
school
medicin
winstonsalem
nc
viru
stock
amplifi
cell
quantifi
plaqu
assay
vero
cell
mous
infect
mice
anesthet
ketaminexylazin
inocul
intranas
pfu
viru
dmem
mice
either
monitor
weight
loss
sacrif
day
post
infect
dpi
harvest
brain
tissu
brain
tissu
homogen
leukocyt
isol
previous
describ
leukocyt
brain
tissu
purifi
use
microbead
miltenyi
biotec
per
manufactur
instruct
surfac
stain
brain
leukocyt
treat
fc
block
incub
specif
mab
isotyp
control
monoclon
antibodi
use
studi
includ
biolegend
thermo
fisher
scientif
cell
analyz
use
fac
vers
flow
cytomet
bd
bioscienc
flow
cytometri
data
analyz
use
flowjo
softwar
tree
star
inc
sirna
knockdown
dsirna
oligonucleotid
purchas
integr
dna
technolog
idt
sequenc
list
tabl
neg
control
dsirna
also
purchas
idt
list
nonspecif
control
bmdm
transfect
pmolml
sirna
virom
blue
lipocalyx
follow
manufactur
protocol
media
replac
hour
transfect
cell
incub
hour
prior
infect
three
independ
sirna
acquir
gene
one
give
best
knockdown
use
viral
replic
assay
except
parp
assay
util
independ
sirna
ko
nhdf
cell
ifnar
ko
cell
gener
use
system
construct
pair
oligo
phosphoryl
anneal
insert
addgen
plasmid
bsmbi
restrict
site
describ
sequenc
oligo
list
tabl
packag
lentivirus
transduct
perform
describ
previous
summari
pool
ko
nhdf
cell
ko
ifnar
ko
cell
line
gener
transduct
lentivirus
hour
post
transduct
nhdf
cell
treat
puromycin
day
cell
dilut
obtain
singl
cell
clone
nhdf
cell
pool
ko
clone
screen
immunoblot
ifnar
ko
cell
ablat
confirm
assess
infect
sensit
nhdf
cell
transduc
irrelev
grna
grnanc
use
neg
control
rna
isol
cell
use
trizol
thermo
fisher
scientif
via
phase
separ
directzol
column
purif
zymo
research
per
manufactur
instruct
cdna
prepar
use
mmlvrevers
transcriptas
per
manufactur
instruct
thermo
fisher
scientif
quantit
pcr
qpcr
perform
realtim
pcr
system
use
powerup
sybr
green
master
mix
thermo
fisher
scientif
qpcr
primer
list
tabl
primer
design
span
exonexon
junction
possibl
prevent
quantif
residu
genom
dna
qpcr
reaction
run
rt
control
confirm
lack
signific
dna
contamin
cycl
threshold
normal
housekeep
gene
hypoxanthineguanin
phosphoribosyltransferas
hprt
follow
equat
c
gene
interest
c
hprt
result
shown
ratio
hprt
calcul
total
cell
lyse
sampl
buffer
contain
sd
proteasephosphatas
inhibitor
cocktail
roch
pmsf
univers
nucleas
thermo
fisher
scientif
protein
resolv
sd
polyacrylamid
gel
transfer
polyvinyliden
difluorid
pvdf
membran
hybrid
primari
antibodi
react
infrar
ir
dyeconjug
secondari
antibodi
visual
use
licor
odyssey
imag
analyz
use
imag
studio
softwar
licor
primari
antibodi
use
immunoblot
includ
antiflag
monoclon
antibodi
milliporesigma
polyclon
antibodi
santa
cruz
biotechnolog
milliporesigma
antipar
monoclon
antibodi
trevigen
rabbit
antimhv
polyclon
antibodi
antiactin
monoclon
antibodi
abcam
secondari
ir
antibodi
purchas
licor
supernat
infect
cell
collect
hpi
protein
level
determin
use
luminex
protein
assay
thermo
fisher
scientif
accord
manufactur
instruct
bmdm
plate
glass
cover
slip
infect
gfpexpress
mhv
hpi
cell
fix
paraformaldehyd
coverslip
transfer
glass
slide
vectashield
antifad
mount
media
dapi
vector
laboratori
appli
second
coverslip
overlaid
slide
visual
olympu
invert
fluoresc
microscop
olympu
imag
analyz
use
slidebook
softwar
meyer
instrument
unpair
twotail
student
ttest
use
assess
differ
mean
valu
group
graph
express
mean
sem
mhv
titer
present
geometr
mean
sem
n
valu
repres
number
biolog
replic
figur
n
wt
virusinfect
sampl
unless
otherwis
indic
signific
p
valu
denot
mice
infect
describ
method
wt
mhv
brain
tissu
collect
dpi
cell
purifi
describ
method
flow
cytometri
use
assess
purif
efficaci
data
one
repres
experi
three
independ
experi
n
b
c
cell
purifi
rna
isol
analyz
viral
genom
rna
grna
indic
time
point
b
parp
mrna
dpi
c
data
b
c
show
one
repres
experi
two
independ
experi
n
wt
except
day
n
sampl
c
n
number
bar
repres
fold
differ
wt
bmdm
transfect
control
sirna
sictl
parpspecif
sirna
describ
method
approxim
hour
later
cell
infect
wt
mhv
collect
hpi
rna
level
determin
rtqpcr
primer
specif
transcript
normal
hprt
level
parp
mrna
sirnatr
cell
normal
express
control
sirnatr
cell
data
show
combin
result
two
five
experi
n
n
n
n
n
n
n
n
